EMA (EU)
EVENT
ACT EU workshop on multiplicity in confirmatory clinical trials: From two-arm to platform trials
Published: 11/27/2026Detected: 11/18/2026
Summary preview
Focuses on how multiplicity adjustments should be handled in regulatory decision-making for confirmatory two-arm and confirmatory platform trial designs.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Committee for Advanced Therapies (CAT): 2-4 December 202612/2/2026
- Committee for Medicinal Products for Veterinary Use (CVMP): 1-3 December 202612/1/2026
- Committee for Orphan Medicinal Products (COMP): 1-3 December 202612/1/2026
- Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection12/1/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/30/2026